Publications
- Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms2024 | Second Faculty of Medicine
- Serum PAI-1/BDNF Ratio Is Increased in Alzheimer's Disease and Correlates with Disease Severity2023 | Second Faculty of Medicine
- Impact of APOE and BDNF Val66Met gene polymorphisms on cognitive functions in patients with amnestic mild cognitive impairment2020 | Second Faculty of Medicine
- The BDNF Val66Met polymorphism modulates resilience of neurological functioning to brain ageing and dementia: A narrative review2020 | Second Faculty of Medicine
- APOE and BDNF as genetic risk markers for predicting the onset and development of cognitive deficits due to Alzheimer's disease2020 | Second Faculty of Medicine
- The Combined Effect of APOE and BDNF Val66Met Polymorphisms on Spatial Navigation in Older Adults2020 | Second Faculty of Medicine
- Amyloid beta soluble forms and plasminogen activation system in Alzheimer's disease: Consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implications2019 | Second Faculty of Medicine
- Meeting summary of The NYO3 5th NO-Age/AD meeting and the 1st Norway-UK joint meeting on ageing and dementia: recent progress on the mechanisms and interventional strategies2024 | Second Faculty of Medicine
- Memory Binding Test and Its Associations With Hippocampal Volume Across the Cognitive Continuum Preceding Dementia2023 | First Faculty of Medicine, Second Faculty of Medicine
- Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid2022 | Second Faculty of Medicine
Loading network view...